| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |